Overview

Early Use of Vasopressin in Post-Fontan Management

Status:
Completed
Trial end date:
2019-01-28
Target enrollment:
0
Participant gender:
All
Summary
This is an investigator initiated, prospective, single-center, double-blinded, randomized, placebo-controlled trial of post-operative low dose vasopressin infusions as an early treatment of low systemic perfusion in pediatric patients following Fontan palliation.
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Medical College of Wisconsin
Treatments:
Arginine Vasopressin
Vasopressins
Criteria
Inclusion Criteria:

- Planned completion of Fontan palliation

- English or Spanish speaking

- Completion of Informed Consent

Exclusion Criteria:

- Previous failed attempts at Fontan completion with subsequent takedown

- Planned concomitant atrioventricular valvuloplasty or neoaortic valve or arch
reconstruction at the time of Fontan completion

- History of renal failure requiring renal replacement therapy

- Absence of informed consent